Alamar Biosciences

• Digital Lifestyle Coaching for Alzheimer's Disease Prevention in APOE4 Carriers

  Collaborator, Enrolling by invitation, 1,200 people, 12 Jun 2026

Sources: clinicaltrials.gov

• Air pollution is associated with sex-specific longitudinal changes in astrocytic and neuroinflammatory processes linked to cognitive decline in Alzheimer's disease at-risk individuals

  Grants or research support, 1 Oct 2026

• Regional amyloid accumulation, post-traumatic distress, and intrusive symptoms in cognitively unimpaired older adults at risk for Alzheimer's

  Grants or research support, 18 Aug 2026

• Serum Klotho Levels, Brain Structure, and Cognitive Performance

  Fees or honoraria, Grants or research support, 1 Mar 2026

• The Alzheimer's Pathways Sleep Study (ALPS): an experimental randomized controlled trial to improve cognition and Alzheimer's pathophysiology through slow-wave sleep

  Grants or research support, 19 Feb 2026

• Cellular Aging Signatures in the Plasma Proteome Record Human Health and Disease

  Consulting or advice, 12 Feb 2026

• Plasma biomarkers, brain amyloid-beta pathology, and cortical thickness in a non-Hispanic White and Black/African American middle-aged community cohort: The HCP-CoBRA study

  Grants or research support, 1 Dec 2025

• Classification accuracies of plasma ptau217 vs. ptau217/Aβ1-42 for brain Aβ pathology in cognitively normal older adults

  Grants or research support, 6 Nov 2025

• Proteomic polygenic risk scores of age-related plasma protein levels reveal a role for Metalloproteinase inhibitor 2 (TIMP2) in cognitive performance

  Grants or research support, 23 Oct 2025

• Synaptic dysfunction and glial activation markers throughout aging and early neurodegeneration: a longitudinal CSF biomarker-based study

  Grants or research support, 17 Oct 2025

Sources: pubmed.ncbi.nlm.nih.gov

• Associations among cognitive performance, VCAM-1, and GFAP in black adults: The ARCHES study

  Neurobiology of aging, 11 Jul 2026

• High Sensitivity Proteomics for Predicting Dementia in Older Adults with Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study

  ADA Scientific Sessions 2026 abstract, 8 Jun 2026

• Proteomic Analysis of NULISATM plasma analytes and Associations with Neurocognitive measures and Incident Dementia in older adults

  AAIC 2025 abstract, 9 Jan 2026

• Examination and Identification of distinct and shared proteomic profiles linked to Alzheimer's Disease biomarkers across multiple proteomic platforms

  AAIC 2025 abstract, 8 Jan 2026

• Potential of dried plasma spot: a comparative study of plasma biomarker quantification using NULISA

  AAIC 2025 abstract, 8 Jan 2026

• Associations between classical Alzheimer's Disease biomarkers and key proteins defining potential pathophysiological mechanisms – A multi‐analyte proteomic analysis

  AAIC 2025 abstract, 8 Jan 2026

• Plasma Neurodegeneration and AD Biomarkers Identify Populations With Rapid Cognitive Decline

  GSA 2025 abstract, 3 Jan 2026

• Comparison of plasma pTau217 assays on different platforms

  AAIC 2025 abstract, 25 Dec 2025

• Examination and Identification of distinct and shared proteomic profiles linked to Alzheimer’s Disease biomarkers across multiple proteomic platforms

  AAIC 2025 abstract, 23 Dec 2025